This Project Grant award of $473,377 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, supports research to modulate the stem cell niche and improve skeletal muscle regeneration. The key objectives are to: Interrogate how muscle cells arise and develop functional characteristics from human pluripotent stem cells (hPSCs) through analysis of myogenic commitment factors and inhibition of...
This federal Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to uncover the fundamental biological and material mechanisms that control bone quality. The $1,469,862 award, with a project period from Sep 5, 2024 to Aug 31, 2029, will fund research at the University of California, San Francisco (UCSF) to investigate how exercise regulates...
The federal Project Grant award of $628,174.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant aims to investigate the cellular origins and molecular mechanisms underlying arthrofibrosis, a debilitating fibrotic joint disorder that results in excessive scar tissue formation and joint immobility. The research will employ genetic mouse models to...
This federal Project Grant award, worth $1,727,423, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under their Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The objective of this 5-year award, which began on August 7, 2024, is to investigate the role of the bone-regulating myokine FGF21 in Duchenne muscular dystrophy (DMD) and its effects on skeletal health. The research will focus on identifying the cellular...
This $483,070 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 "Arthritis, Musculoskeletal and Skin Diseases Research" supports research into the dynamics of bone extracellular matrix (ECM) assembly and resorption. The study aims to investigate how osteogenic cellular dynamics, differentiation, and cell fate are integrated with collagen assembly and mineralization, as well as how osteoclast bone resorption...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $220,224 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to The Regents of the University of Colorado, operating as the University of Colorado, with a period of performance from July 4, 2024 to August 31, 2027. The funding will support the development of granular hydrogels for the controlled delivery of immunomodulatory and angiogenic extracellular vesicles to enhance...
This $600,475 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) aims to develop a collagen-based scaffold modified with specific integrin ligands and placental mesenchymal stem cell-derived extracellular vesicles. This engineered scaffold is intended to synergistically recruit and guide endogenous stem cells for vascularized bone regeneration in...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $557,357 to the University of Wisconsin System to study the role of HOX-expressing interstitial cells in skeletal muscle growth, homeostasis, and regeneration. The research aims to interrogate the potential of these cells to contribute to muscle development and repair, with the goal...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $649,391 to The Johns Hopkins University to conduct research aimed at enhancing healing and regeneration after injury or infection to epithelial tissues like skin and gut. The research seeks to define mechanisms that restrain healing in hopes of developing new therapies to improve...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $522,334 to develop a computational data repository called BoneBase that will collect and share bone phenotyping data from rodent animal models. The project aims to build a sustainable, cloud-based platform to ingest, curate, and publicly share quantitative skeletal data generated...